FHI vs MAIN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

FHI

31.7
AI Score
VS
MAIN Wins

MAIN

38.8
AI Score

Investment Advisor Scores

FHI

32score
Recommendation
EXTENDED

MAIN

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI MAIN Winner
Forward P/E 10.9529 15.4799 FHI
PEG Ratio 1.543 1.7605 FHI
Revenue Growth 8.1% 3.9% FHI
Earnings Growth 11.9% 15.3% MAIN
Tradestie Score 31.7/100 38.8/100 MAIN
Profit Margin 21.3% 78.5% MAIN
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY FHI

Relative Price Performance (Last 90 Days)

FHI 1M: +14.4% · 3M: +1.3% MAIN 1M: +4.7% · 3M: -2.6%

Current Technical Phase

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 68.2 · Price: $63.99

MAIN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 61.8 · Price: $57.01

Fundamentals Snapshot

Metric FHI MAIN
Market Cap — —
Forward P/E 10.7 14.7
Trailing P/E 11.9 11.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% 1.0%
Operating Margin 0.3% 0.9%
EPS 5.39 4.98
Dividend Yield 0.02% 0.05%

Frequently Asked Questions

Based on our detailed analysis, MAIN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.